Spironolactone use and the risk of breast and gynecologic cancers
| Data(s) |
2013
|
|---|---|
| Identificador | |
| Publicador |
Elsevier Inc |
| Relação |
DOI:10.1016/j.canep.2013.10.004 Biggar, Bob, Anderson, Elisabeth, Wohlfahrt, Jan, & Melbye, Mads (2013) Spironolactone use and the risk of breast and gynecologic cancers. Cancer Epidemiology, 37(6), pp. 870-875. |
| Fonte |
Faculty of Built Environment and Engineering; Institute of Health and Biomedical Innovation |
| Palavras-Chave | #estrogen, furosemide, prescription drug, spironolactone, adult, aged, article, breast cancer, cancer diagnosis, cancer incidence, cancer risk, drug use, female, gynecologic cancer, human, major clinical study, priority journal, risk assessment, uterine c |
| Tipo |
Journal Article |
